Our core services, clinical data management, biostatistics and statistical programming, are anchored by extensive early phase experience, real time access to biometrics experts and cost-effective technologies.
Full Service Biometrics
As a full-service biometrics provider we act as an inhouse biometrics partner or work in collaboration with other organizations to support all the biometrics activities for a project, read more.
Our data management team collaborates with other organizations to design, build and maintain EDC solutions on the partner’s behalf. We have supported several Australian CROs faced with resource constraints, ensuring that the trial start-up timelines were met, handling all mid-trial database modifications, and locking the database, read more.
Our biostatisticians have extensive experience helping clients to design clinical trials. We support all aspects of protocol development, including sample size calculations, endpoint identification and advising on statistical methodology, read more.
Our statistical programmers have complemented sponsor teams with inhouse data management and biostatistics teams, supporting all the statistical programming activities from creating CDISC data packages to generating the tables, listings, and figures in accordance with the sponsor’s statistical analysis plan, read more.
Biostatistics and Statistical Programming
Our team has extensive experience partnering with other organizations that only offers data management services.
Under this model, our biostatistics and statistical programming team assumes full responsibility for all biostatistics deliverables, working with the partner’s data management team to perform the data analysis, read more.
Our team has extensive experience in rescuing ongoing studies when other biometric providers need help. Our inaugural project was a rescue project that was successfully delivered on time and within budget, read more.
What our clients are saying about us
“Avecho engaged Resolutum Global for the first time on our recent Phase I PK study. Moses and the team were highly professional and capable, whilst being agile enough to accommodate the changing needs of small Biotech. Data management and stats were performed to the highest quality, on time and on budget. We would definitely use Resolutum again and recommend them to our peers in the space.”
CEO – Avecho
“Resolutum Global has a highly experienced and friendly team that provided a local solution in biometrics for our Phase I clinical study. The team showed their dedication by catering for our needs in a timely and professional manner”
Dr Francesca Mercuri
Director, Operations – ENA Respiratory
“Resolutum Global have now supported two clinical studies sponsored by Amplia and on both occasions their technical know-how, responsiveness and ‘can-do’ attitude have been excellent. Working with a local data management provider that understands our priorities has also been a refreshing change for us.”
CEO and Managing Director – Amplia Therapeutics
“RG was absolutely excellent for the statistical analyses for our phase 1 trial and conducted all aspects of the project in an extremely efficient, professional manner. RG’s attention to every detail was evident in the excellent quality of the statistical analysis plan, table shells, final tables, figures, and listings, and CDISC datasets. Their effective and responsive communication promoted a seamless transition from study execution to reporting the trial results.”
Lyn Frumkin, MD, PhD
SPARK at Stanford
“RG has been a very diligent, proactive and professional partner to help complete a complex project of a certain vintage. The quality of its medical writing personnel is extremely high and RG has consistently pursued a collaborative path to resolve long-standing issues to every stakeholders’ appreciation. The Managing Director is very approachable and pragmatic; Moses Mwangi is a trusted partner whose transparency, candour and expertise exceeds expectations. I would certainly recommend RG as a very good vendor in a research industry where reputation matters, and those that add value without adding cost are priceless.”
Senior Manager – Clinical Development Life Sciences